Inactive Instrument

Insiders OXFORD BIOMEDICA Swiss Exchange

Equities

Oxford Biomedica plc Announces Board Changes	11/03	CI
EnSilica hires new chief financial officer from Oxford Biomedica	05/02	AN
EnSilica Appoints Oxford Biomedica Executive as CFO	05/02	MT
Ashley sells put options for million Frasers shares	20/23/20	AN
Oxford Biomedica plc Appoints Leone Patterson as an Independent Non-Executive Director, Effective May 1, 2023	26/23/26	CI
Oxford Biomedica plc Announces Management Changes	20/23/20	CI
Oxford Biomedica plc Appoints Frank Mathias as Chief Executive Officer, Effective March 27, 2023	20/23/20	CI
Oxford Biomedica Appoints First Vice Chair	20/23/20	MT
Oxford BioMedica confirms start date of Mathias as new CEO	20/23/20	AN
Oxford Biomedica's New CEO to Take Office end-March	20/23/20	MT
Oxford Biomedica plc Announces Siyamak Rasty Will Not Be Standing for Re-Election	27/23/27	CI
IN BRIEF: Oxford BioMedica appoints Frank Mathias as new CEO	22/22/22	AN
Oxford Biomedica Names New CEO	22/22/22	MT
Oxford Biomedica Appoints Frank Mathias as CEO	22/22/22	CI
Oxford Biomedica Appoints Frank Mathias as Board Director	22/22/22	CI
Oxford Biomedica plc Re-Appoints Kmpg LLP as Auditor	27/22/27	CI
John Dawson Has Steps Down from the Oxford Biomedica Plc's Board of Directors	27/22/27	CI
Oxford Biomedica plc Announces the Appointment of Namrata P Patel as Independent Non-Executive Director	13/22/13	CI
Sio Gene Therapies Ends Gene Therapy Program for Parkinson's Disease, Names New CEO	01/22/01	MT
Oxford Biomedica plc Announces Roch Doliveux as Chair of the Group’s Board	28/22/28	CI

No results for this search